General Manager: National Tobacco Control Advocacy Service

30 Nov 2017 1:35 PM | Anonymous

The Hāpai National Tobacco Control Advocacy Service facilitates engagement between a wide range of policy makers, decision makers/influencers that may include, parliamentary committees, the Ministry of Health, District Health Boards, NGOs, Primary Health Organisations, corporate stakeholders, media, stop smoking service providers, local councils, Māori and Pacific providers, Iwi, local and national businesses, research and academic institutions, territorial local authorities, crown agencies and communities to progress Smokefree 2025.

Our Tobacco Control Advocacy service utilises relationships and key influencers to spur increased ownership, and a positive view of Smokefree 2025, it identifies, delivers and promotes effective public health and advocacy interventions that will create and strengthen Smokefree policies. Our role is also to increase public and media understanding of what will get us to 2025.

The four key objectives of all Hāpai tobacco control advocacy activities are:

  1. To reduce smoking initiation,
  2. To increase quitting,
  3. To reduce the social, economic and health harms of tobacco,
  4. To reduce inequalities

The General Manager leads a small interdisciplinary team, with reporting accountability to the CEO of Hāpai Te Hauora. This is a service which advocates for all New Zealanders but has a Māori and Pacific focus due to the inequitable burden of tobacco-related harm on these communities. This role therefore requires a leader with experience working in culturally diverse environments. 

The successful applicant will have: 

  • Leadership and management experience
  • A relevant tertiary qualification
  • Strong communications and media engagement skills
  • Previous experience in public health advocacy 

Applications close 8th December 2017 at 5pm. Please provide a CV and cover letter with your application using the link HERE

Public Health Association Logo

PHA Conference


Get curious

Get engaged

Get involved


Upcoming events

  • No upcoming events

The PHA – a strong and informed collective voice for a healthy and well New Zealand.

Privacy | Contact

Copyright © Public Health Association of New Zealand 2016

Login

Letter to the Listener 28 July 2017 in response to Fever Pitch (Listener 21 July 2017)

Catherine Woulfe’s thorough investigation of rheumatic fever brings to the surface a range of important questions not only about this cruel disease, but also wider issues about health policy. The Government’s bold initiative to reduce the incidence of rheumatic fever as one of its 'Better Public Service' targets in 2012 certainly raised awareness of rheumatic fever for the general public as well as communities and families directly affected. But even when medical science and the public have a clearer understanding of the immediate causes of rheumatic fever, interventions like the $65m ‘sore throats matter’ still won’t stop the epidemic. 

Ramona Tiatia’s blunt description of the experience of affected families not only painted a picture of the impact on affected families and communities, it also highlighted the invidious choices our health funders face.  How much should we prioritise health spending between response to the urgent need of young people whose lives and potential can be devastated by the disease versus the expense of addressing the economic and social factors that underlie the reasons we have this epidemic at all?   

As several of the clinicians interviewed pointed out, it’s only when the poverty and over-crowded housing issues are addressed that we will make a real difference.

Rheumatic fever illustrates the contradictions in our health system identified in the recent American Commonwealth Fund report. Of the 11 countries the Fund monitors, the work our health professionals do is ranked among the highest. But our overall performance as a health system falls to the middle ranking because of our poor performance on access and equity. The Fund also notes that our per capita expenditure is among the cheapest. 

Failure to invest in real prevention - that is, poverty, housing, good nutrition etc. - will continue to drive conditions like rheumatic fever, whether the immediate cause is strep throat or skin sores, until we invest upstream.

Why not spend more on these conditions - the economic and social determinants of health? 

We all pay in the long run - the young people whose misery we tolerate and whose potential remains unfulfilled, the families whose sacrifices are unrewarded, and the taxpayer who picks up the tab.

Ngā mihi,
Warren Lindberg

CE Public Health Association of New Zealand

                                            

Powered by Wild Apricot Membership Software